Sunshine Biopharma Inc Working Capital to Net Assets Ratio
Sunshine Biopharma Inc working capital to net assets ratio. Sunshine Biopharma Inc (SBFM) has a Working Capital to Net Assets ratio of 91.0% as of June 2026. Working capital of $25.05 Million (current assets of $30.67 Million minus current liabilities of $5.62 Million) is measured against net assets of $27.54 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Sunshine Biopharma Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Sunshine Biopharma Inc (2007–2025)
Working capital to net assets ratio of Sunshine Biopharma Inc from 2007 to 2025. This chart shows how Sunshine Biopharma Inc's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the ratio stands at 91.0%, reflecting working capital of $25.05 Million against net assets of $27.54 Million USD. See Sunshine Biopharma Inc (SBFM) liquidity interval to measure how many days the company can operate on defensive assets alone.
Sunshine Biopharma Inc Working Capital to Net Assets Ratio by Year (2007–2025)
Sunshine Biopharma Inc working capital to net assets ratio by year from 2007 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Sunshine Biopharma Inc from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Sunshine Biopharma Inc total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 88.6% | $20.41 Million | $23.04 Million | $26.85 Million | $6.44 Million | ▲ +5.0 pp |
| 2024 | 83.6% | $19.65 Million | $23.50 Million | $25.97 Million | $6.31 Million | ▼ -7.6 pp |
| 2023 | 91.2% | $19.34 Million | $21.21 Million | $24.89 Million | $5.55 Million | ▼ -3.1 pp |
| 2022 | 94.2% | $20.38 Million | $21.63 Million | $27.31 Million | $6.93 Million | ▼ -900.1 pp |
| 2021 | 994.3% | $2.10 Million | $211.66K | $2.20 Million | $91.23K | ▲ +991.7 pp |
| 2020 | 2.7% | $-25.36K | $-954.84K | $1.03 Million | $1.05 Million | ▼ -101.8 pp |
| 2019 | 104.4% | $-767.84K | $-735.38K | $65.69K | $833.53K | ▼ -1152.9 pp |
| 2018 | 1257.3% | $-700.97K | $-55.75K | $211.51K | $912.48K | ▲ +1146.7 pp |
| 2017 | 110.6% | $-633.94K | $-573.36K | $117.20K | $751.14K | ▲ +7.7 pp |
| 2016 | 102.8% | $-215.64K | $-209.70K | $58.46K | $274.10K | ▼ -100.9 pp |
| 2015 | 203.7% | $-1.22 Million | $-597.04K | $53.91K | $1.27 Million | ▲ +103.7 pp |
| 2014 | 100.0% | $-387.58K | $-387.58K | $143.42K | $531.00K | ▲ +0.0 pp |
| 2013 | 100.0% | $-7.71K | $-7.71K | $31.24K | $38.95K | ▲ +0.0 pp |
| 2012 | 100.0% | $70.43K | $70.43K | $134.79K | $64.37K | ▲ +0.0 pp |
| 2011 | 100.0% | $103.00K | $103.00K | $106.44K | $3.43K | ▲ +0.0 pp |
| 2010 | 100.0% | $196.22K | $196.22K | $207.62K | $11.40K | ▲ +0.0 pp |
| 2009 | 100.0% | $97.80K | $97.80K | $112.12K | $14.31K | ▲ +0.0 pp |
| 2008 | 100.0% | $-17.71K | $-17.71K | $5.03K | $22.74K | ▲ +0.0 pp |
| 2007 | 100.0% | $13.39K | $13.39K | $14.89K | $1.50K | — |